EUVIMEDObjevte EUVIMED
Crossref

In Situ Heparan Sulfate-Induced Peptide Self-Assembly to Overcome the Cell Surface Glycocalyx Barrier for Cancer Treatment

Pengfei Pei, Long Chen iD, Xinyao Guan, Peng Wei iD, Xiaoxu Kang, Lili Gong iD, Lihong Liu, Wenxu Guo, Renji Gu, Lixin Wang, Chuanke Zhao, Jun F Liang and 1 more

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c09243 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2024. Written by Pengfei Pei and 12 co-authors. Institution: State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100…. Major MEDLINE topics: Heparan Sulfate, Glycocalyx, Peptides, Antineoplastic Agents. Cited 2 times so far (Crossref); 58 references. Funded by: National Key Research and Development Program of China, China Postdoctoral Science Foundation, China-Japan Friendship Hospital.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Heparan sulfate (HS) is a major component of cell surface glycocalyx with extensive negative charges and plays a protective role by preventing toxins, including small molecule drugs and anticancer cationic lytic peptides (ACLPs), from cells. However, this effect may compromise the treatment efficiency of anticancer drugs. To overcome the impedance of cancer cell glycocalyx, an HS-targeting ACLP PTP-7z was designed by fusion of an ACLP and a Zn2+-binding HS-targeting peptide. Upon Zn2+ ion binding, PTP-7z could self-assemble into uniform nanoparticles and show improved serum stability and reduced hemolysis, which enable it to self-deliver to tumor sites. The peptide PTP-7z showed a pH- and Zn2+ ion-dependent HS-binding ability, which triggers the HS-induced in situ self-assembling on the cancer cell surface in the acidic tumor microenvironment (TME). The self-assembled PTP-7z can overcome the impedance of cell glycocalyx by either disrupting cell membranes or translocating into cells through endocytosis and inducing cell apoptosis. Moreover, PTP-7z can also inhibit cancer cell migration. These results proved that HS-responsive in situ self-assembling is a practical strategy to overcome the cancer cell glycocalyx barrier for ACLPs and could be extended to the design of other peptide drugs to promote their in vivo application.

Subjects

MeSH terms (MEDLINE)

Heparan SulfateGlycocalyxPeptidesAntineoplastic AgentsHumansAnimalsNeoplasmsMiceApoptosisCell Line, TumorCell MovementTumor MicroenvironmentNanoparticles

Author keywords

ACLPHS targetingcharge conversionglycocalyx barrierin situ self-assembling

Substances

Heparan SulfatePeptidesAntineoplastic Agents

Authors and institutions

  • State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
  • School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, China.
  • Institute of Medical Science, China-Japan Friendship Hospital, Beijing 100029, China.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Department of Chemistry, Chemical Biology, and Biomedical Engineering, Stevens Institute of Technology, Hoboken, New Jersey 07030, United States.

ORCID profiles: Long Chen, Peng Wei, Lili Gong

Funding

  • National Key Research and Development Program of China
  • China Postdoctoral Science Foundation
  • China-Japan Friendship Hospital
  • Beijing University of Chemical Technology
  • Natural Science Foundation of Beijing Municipality
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing

Cite

APA

Pei, P., Chen, L., Guan, X., Wei, P., Kang, X., Gong, L., Liu, L., Guo, W., Gu, R., Wang, L., Zhao, C., Liang, J. F., & Luo, S. Z. (2024). In Situ Heparan Sulfate-Induced Peptide Self-Assembly to Overcome the Cell Surface Glycocalyx Barrier for Cancer Treatment. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c09243

Vancouver

Pei P, Chen L, Guan X, Wei P, Kang X, Gong L, et al. In Situ Heparan Sulfate-Induced Peptide Self-Assembly to Overcome the Cell Surface Glycocalyx Barrier for Cancer Treatment. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c09243

BibTeX
@article{Pei2024,
  author = {Pei, Pengfei and Chen, Long and Guan, Xinyao and Wei, Peng and Kang, Xiaoxu and Gong, Lili and Liu, Lihong and Guo, Wenxu and Gu, Renji and Wang, Lixin and Zhao, Chuanke and Liang, Jun F and Luo, Shi-Zhong},
  title = {In Situ Heparan Sulfate-Induced Peptide Self-Assembly to Overcome the Cell Surface Glycocalyx Barrier for Cancer Treatment},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c09243}
}
Start for free →